News
Mim8 (denecimig) prophylaxis was well-tolerated in FRONTIER5 phase 3 switch trial in people with haemophilia A · New FRONTIER5 data shows direct switch to Mim8 prophylaxis treatment from ...
Beloved of celebrities from Hailey Bieber to Jennifer Aniston, NAD+ promises a whole host of benefits. I tried it..
Compounded weight loss drugs have been mostly off the market for about a month, but the weight loss drug industry remains as unsettled as ever.
Ahead of iPhone 17 launch, iPhone 16 Pro Max gets price cut on Flipkart: Here is how to get the deal
The iPhone 16 Pro Max is currently available on Flipkart with a notable price cut. Check how you can grab the deal and ...
Wegovy, a weekly weight-loss injection by Novo Nordisk, has launched in India. Priced from Rs 17,000/month, it helps users lose up to 20 per cent body weight. But is it safe? Experts answer.
3d
Medpage Today on MSNOnce-Weekly Basal Insulin Non-Inferior to Several Daily Options in Type 2 DiabetesCHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the ...
2d
Zacks Investment Research on MSNNVO Reports New Positive Phase III Data on Mim8 in Hemophilia ANovo Nordisk NVO announced new data from the phase III FRONTIER clinical program, comprising five separate studies evaluating ...
AstraZeneca's first-in-class severe asthma therapy Tezspire has been approved in the EU in a new pen injector formulation suitable for administration by patients themselves. The green light for ...
Great Britain will be the first major market to be supplied with the drug in the multi-shot pen injector format. Like the earlier single-dose version, which was approved by the MHRA last year, ...
Directly switching from Hemlibra to Mim8 was well tolerated in people with hemophilia A, with or without inhibitors, a study ...
1d
India Today on MSNWeight-loss and new-age drugs: Dr Ambrish Mithal on Wegovy's India debutWith the weight-loss blockbuster drug Wegovy, now in India, renowned endocrinologist and diabetologist Dr. Ambrish Mithal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results